Picture of Hyloris Pharmaceuticals SA logo

HYL — Hyloris Pharmaceuticals SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Brief: Hyloris Launches Equity Offering To Raise Around EUR 15 Million

March 31 (Reuters) - Hyloris Pharmaceuticals SA  HYL.BR :
    * HYLORIS LAUNCHES EQUITY OFFERING BY MEANS OF A PRIVATE
PLACEMENT
VIA AN ACCELERATED BOOKBUILD OFFERING
    * LAUNCH OF AN EQUITY OFFERING TO RAISE AN AMOUNT OF
APPROXIMATELY
EUR 15 MILLION BY MEANS OF A PRIVATE PLACEMENT VIA AN
ACCELERATED BOOKBUILD OFFERING
    * OFFERING WILL NOT BE OPEN TO PUBLIC
    * HYLORIS CURRENTLY ENVISAGES USING NET PROCEEDS OF OFFERING
TO:PRIMARILY FUND DEVELOPMENT OF ADDITIONAL NEW PRODUCT
CANDIDATES
    * BOARD OF DIRECTORS OF COMPANY HAS DECIDED TO CANCEL
PREFERENTIAL
SUBSCRIPTION RIGHTS OF EXISTING SHAREHOLDERS IN CONTEXT OF
OFFERING
    * POSSIBILITY TO INCREASE SIZE OF OFFERING
    * EXISTING SHAREHOLDERS NOSHAQ SA AND S.R.I.W. SA ARE
SUPPORTIVE
OF OFFERING AND HAVE INDICATED AN INTENTION TO SUBMIT AN ORDER.
    * EXISTING SHAREHOLDERS NOSHAQ SA AND S.R.I.W. SA ARE
SUPPORTIVE
OF OFFERING AND HAVE INDICATED AN INTENTION TO SUBMIT AN ORDER.
    * ENVISAGSE TO USE NET PROCEEDS TO ACCELERATE IN-HOUSE
RESEARCH
AND DEVELOPMENT ACTIVITIES, INCLUDING REPURPOSING AND ANALYTICAL
EXPERTISE.
    * TRADING IN SHARES IS EXPECTED TO RESUME FOLLOWING
PUBLICATION OF
RESULTS OF OFFERING.
    * IN RELATION TO OFFERING, COMPANY HAS AGREED WITH
UNDERWRITERS TO
A MARKET CUSTOMARY 180-DAYS STANDSTILL PERIOD ON FUTURE SHARE
ISSUANCES, WAIVABLE BY UNDERWRITERS AND SUBJECT TO CUSTOMARY
EXCEPTIONS.

Source text for Eikon:  ID:nGNE6j1X1Y 
Further company coverage:  HYL.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Hyloris Pharmaceuticals SA

See all news